Zenas BioPharma CEO Adds $1.02 Million in Stock Purchases Amid Fundraising and Positive Trial News
Zenas BioPharma Chief Executive Leon O. Moulder Jr. bought $1,021,140 of common stock in two transactions on March 30 and March 31, 2026, increasing his direct and indirect holdings. The insider purchases occurred as the share price slid nearly 12% over the prior week and 46% year-to-date. The company concurrently priced public offerings including …